The drug company Moderna has released encouraging data from research on its COVID-19 vaccine candidate. The research has not yet been published in a peer-reviewed medical journal, but it is nonetheless raising hopes. Noubar Afeyan is a co-founder and chairman of Moderna and the CEO of Flagship Pioneering, a venture capital firm that helped launch Moderna. He joins Judy Woodruff to discuss.
Stream your PBS favorites with the PBS app:
Find more from PBS NewsHour at
Subscribe to our YouTube channel:
Follow us:
Facebook:
Twitter:
Instagram:
Subscribe:
PBS NewsHour podcasts:
Newsletters:
